Conestoga Capital Advisors’s NRC Health Common Stock NRC Stock Holding History

Conestoga Capital Advisors’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-47,655	Closed	-$1.09M	–	125
2024 Q2	$1.09M	Sell	47,655 -737,001	-94%	-$22.7M	0.02%	91
2024 Q1	$31.1M	Buy	784,656 +3,850	+0.5%	+$152K	0.45%	51
2023 Q4	$30.9M	Buy	780,806 +7,591	+1%	+$318K	0.46%	49
2023 Q3	$34.3M	Buy	773,215 +43,475	+6%	+$1.9M	0.59%	47
2023 Q2	$31.8M	Sell	729,740 -4,103	-0.6%	-$180K	0.5%	49
2023 Q1	$31.9M	Buy	733,843 +6,097	+0.8%	+$269K	0.53%	48
2022 Q4	$27.1M	Sell	727,746 -3,875	-0.5%	-$150K	0.51%	48
2022 Q3	$29.1M	Buy	731,621 +486	+0.1%	+$18K	0.57%	47
2022 Q2	$28M	Buy	731,135 +2,838	+0.4%	+$103K	0.51%	48
2022 Q1	$28.9M	Buy	728,297 +440	+0.1%	+$17.2K	0.44%	51
2021 Q4	$30.2M	Buy	727,857 +73,597	+11%	+$3.2M	0.39%	51
2021 Q3	$27.6M	Sell	654,260 -36,533	-5%	-$1.84M	0.38%	53
2021 Q2	$31.7M	Sell	690,793 -7,654	-1%	-$364K	0.46%	52
2021 Q1	$32.7M	Buy	698,447 +7,179	+1%	+$349K	0.49%	48
2020 Q4	$29.6M	Buy	691,268 +16,474	+2%	+$846K	0.47%	49
2020 Q3	$33.2M	Buy	674,794 +28,630	+4%	+$1.58M	0.67%	47
2020 Q2	$37.6M	Buy	646,164 +28,454	+5%	+$1.5M	0.82%	47
2020 Q1	$28.1M	Buy	617,710 +2,753	+0.4%	+$165K	0.82%	46
2019 Q4	$40.5M	Sell	614,957 -7,573	-1%	-$463K	0.98%	46
2019 Q3	$36M	Sell	622,530 -4,348	-0.7%	-$269K	0.92%	46
2019 Q2	$36.1M	Buy	626,878 +15,789	+3%	+$730K	0.9%	44
2019 Q1	$23.6M	Buy	611,089 +2,996	+0.5%	+$117K	0.66%	48
2018 Q4	$23.2M	Buy	608,093 +33,074	+6%	+$1.27M	0.74%	46
2018 Q3	$22.2M	Buy	575,019 +84,528	+17%	+$3.21M	0.57%	49
2018 Q2	$18.3M	Buy	490,491 +97,900	+25%	+$3.41M	0.59%	49
2018 Q1	$11.5M	Sell	392,591 -60,845	-13%	-$2.04M	0.44%	49
2017 Q4	$16.9M	Buy	453,436 +31,505	+7%	+$1.12M	0.65%	47
2017 Q3	$15.9M	Buy	421,931 +516	+0.1%	+$16.2K	0.7%	48
2017 Q2	$11.3M	Buy	421,415 +20,795	+5%	+$508K	0.59%	48
2017 Q1	$7.89M	Sell	400,620 -5,635	-1%	-$104K	0.48%	48
2016 Q4	$7.72M	Buy	406,255 +1,415	+0.3%	+$23.4K	0.51%	47
2016 Q3	$6.59M	Sell	404,840 -3,440	-0.8%	-$54K	0.45%	48
2016 Q2	$5.59M	Sell	408,280 -571,750	-58%	-$8.06M	0.41%	48
2016 Q1	$15.2M	Buy	980,030 +167,798	+21%	+$2.46M	1.03%	43
2015 Q4	$13M	Sell	812,232 -3,835	-0.5%	-$58.3K	1.05%	41
2015 Q3	$9.74M	Sell	816,067 -109,919	-12%	-$1.46M	0.78%	43
2015 Q2	$13.2M	Sell	925,986 -4,165	-0.4%	-$59K	0.91%	42
2015 Q1	$13.4M	Sell	930,151 -23,905	-3%	-$338K	0.92%	44
2014 Q4	$13.3M	Sell	954,056 -24,484	-3%	-$360K	0.93%	44
2014 Q3	$12.7M	Buy	978,540 +24,315	+3%	+$334K	0.93%	46
2014 Q2	$13.3M	Sell	954,225 -17,193	-2%	-$259K	0.9%	48
2014 Q1	$16.1M	Buy	971,418 +74,227	+8%	+$1.24M	1.02%	40
2013 Q4	$16.9M	Sell	897,191 -1,516	-0.2%	-$26.6K	1.13%	40
2013 Q3	$16.9M	Sell	898,707 -11,335	-1%	-$195K	1.45%	37
2013 Q2	$16.4M	Buy	+910,042	New	+$14.5M	1.69%	32

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.24B AUM 31.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Conestoga Capital Advisors's NRC Position: Q3 2024 in Review

Conestoga Capital Advisors sold out of NRC Health Common Stock (NRC) in Q3 2024, closing a stake of 47,655 shares — an estimated $1.09M sold.

Conestoga Capital Advisors first reported a position in NRC in Q2 2013 and held it in 45 quarters. The position peaked at $40.5M in Q4 2019. 138 funds tracked by Wall St. Rank hold NRC as of Q3 2024.

Conestoga Capital Advisors reported no remaining NRC Health Common Stock position as of Q3 2024 after selling out during the quarter.
Conestoga Capital Advisors sold 47,655 NRC Health Common Stock shares in Q3 2024, an estimated $1.09M.
Conestoga Capital Advisors first reported a position in NRC Health Common Stock in Q2 2013 and held it in 45 quarters.
Conestoga Capital Advisors's NRC Health Common Stock position peaked at $40.5M in Q4 2019.
138 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2024.

Based on Conestoga Capital Advisors's 13F filing for Q3 2024, filed 28 Oct 2024.